Keros Therapeutics Inc. (KROS) Social Stream
KEROS THERAPEUTICS INC (KROS) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering KEROS THERAPEUTICS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-03-10 | 3 | $100 | $75 | $86.25 | $48.19 | 78.98% |
| 2022-05-09 | 4 | $100 | $75 | $86.25 | $48.19 | 78.98% |
| 2022-06-10 | 4 | $120 | $75 | $93.75 | $48.19 | 94.54% |
| 2022-08-05 | 5 | $120 | $75 | $91 | $48.19 | 88.84% |
| 2022-09-13 | 5 | $120 | $75 | $94 | $48.19 | 95.06% |
| 2022-11-07 | 6 | $120 | $75 | $95 | $48.19 | 97.14% |
| 2023-02-08 | 6 | $120 | $75 | $96.666 | $48.19 | 100.59% |
| 2023-03-08 | 7 | $120 | $75 | $96.666 | $48.19 | 100.59% |
| 2023-05-25 | 7 | $110 | $75 | $95 | $48.19 | 97.14% |
| 2023-07-26 | 8 | $110 | $65 | $90.714 | $48.19 | 88.24% |
| 2023-08-08 | 9 | $110 | $65 | $90.125 | $48.19 | 87.02% |
| 2023-11-07 | 9 | $110 | $66 | $90.25 | $48.19 | 87.28% |
| 2023-11-13 | 9 | $105 | $60 | $85.285 | $48.19 | 76.98% |
| 2023-12-08 | 10 | $105 | $60 | $82.125 | $48.19 | 70.42% |
The Trend in the Analyst Price Target
Over the past 18 months, KROS's average price target has gone down $11.62.
Over the past 43 weeks, KROS's average upside potential has been 136.69%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-05-25 | 7 | 110 | 75 | 95.000 | 50.25 | 89.05% |
| 2023-08-07 | 9 | 110 | 65 | 90.125 | 40.42 | 122.97% |
| 2023-11-06 | 9 | 110 | 66 | 90.250 | 31.69 | 184.79% |
| 2023-11-13 | 9 | 105 | 60 | 87.750 | 29.99 | 192.6% |
| 2023-12-08 | 10 | 105 | 60 | 82.125 | 35.65 | 130.36% |
KROS Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 10 | 0 | 0 | 0 | 0 | 10 |
The Trend in the Broker Recommendations
KROS's average broker recommendation rating improved by 0 over the prior 14 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for KROS as an investment opportunity.
- In the context of all US stocks, KEROS THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 1398.67% of them.
- In the context of stocks in the small market cap category, KEROS THERAPEUTICS INC's average analyst price target is higher than 1765.67% of them.
- KEROS THERAPEUTICS INC's number of analysts covering the stock is higher than 1330.73% of stocks in the small market cap category.
- KROS has a lower variance in analysts' estimates than -440.09% of Pharmaceutical Products stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to KEROS THERAPEUTICS INC are ARQT, RAPT, and TFFP.
View All Top Stocks by Price Target
Is KROS a Buy, Hold or Sell? See the POWR Ratings now!